Edwards Lifesciences (EW) Price & Analysis

Compare

1,917 Followers

EW Stock Chart & Stats

$85.78

$0.80(1.09%)

At close: Jan 08 4:00 PM EST

$85.78

$0.80(1.09%)

Day’s Range― - ―

52-Week Range$65.94 - $87.40

Previous CloseN/A

Volume821.68K

Average Volume (3M)4.59M

Market Cap

$49.16B

Enterprise Value$42.41B

Total Cash (Recent Filing)$3.84B

Total Debt (Recent Filing)$700.30M

Price to Earnings (P/E)36.1

Beta0.71

Next Earnings

Feb 04, 2026

EPS Estimate

0.62

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.67

Shares Outstanding580,300,000

10 Day Avg. Volume3,330,334

30 Day Avg. Volume4,594,415

Financial Highlights & Ratios

PEG Ratio0.05

Price to Book (P/B)4.43

Price to Sales (P/S)8.13

P/FCF Ratio152.63

Enterprise Value/Market Cap0.86

Enterprise Value/Revenue7.21

Enterprise Value/Gross Profit9.21

Enterprise Value/Ebitda24.34

Forecast

1Y Price Target

$95.10

Price Target Upside10.87% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering24

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Financial PerformanceOperating margins are expanding, which aligns with the growth playbook and indicates financial health.

TAVR Segment GrowthEdwards Lifesciences' TAVR segment regained momentum due to improving hospital capacity constraints and renewed focus on the TAVR procedure following positive results.

Transcatheter Mitral And Tricuspid TherapiesThe Transcatheter Mitral and Tricuspid Therapies (TMTT) segment is projected to reach $2B in sales by 2030, supported by a broad portfolio of repair and replacement devices.

Bears Say

Edwards Lifesciences News

Edwards Lifesciences price target raised to $100 from $95 at RBC Capital

RBC Capital analyst Shagun Singh raised the firm’s price target on Edwards Lifesciences (EW) to $100 from $95...

9h ago

Edwards Lifesciences price target raised to $92 from $90 at Truist

Truist raised the firm’s price target on Edwards Lifesciences (EW) to $92 from $90 and keeps a Hold...

9h ago

Edwards Lifesciences price target raised to $92 from $90 at UBS

UBS raised the firm’s price target on Edwards Lifesciences (EW) to $92 from $90 and keeps a Neutral...

10h ago

Edwards Lifesciences price target raised to $88 from $83 at Baird

Baird analyst David Rescott raised the firm’s price target on Edwards Lifesciences (EW) to $88 from $83 and...

11h ago

Edwards Lifesciences price target raised to $100 from $95 at Stifel

Stifel raised the firm’s price target on Edwards Lifesciences (EW) to $100 from $95 and keeps a Buy...

11h ago

Edwards Lifesciences price target raised to $89 from $84 at Canaccord

Canaccord analyst William Plovanic raised the firm’s price target on Edwards Lifesciences (EW) to $89 from $84 and...

11h ago

Edwards Lifesciences price target raised to $96 from $95 at Wells Fargo

Wells Fargo analyst Larry Biegelsen raised the firm’s price target on Edwards Lifesciences (EW) to $96 from $95...

12h ago

Edwards Lifesciences price target raised to $103 from $100 at BTIG

BTIG analyst Marie Thibault raised the firm’s price target on Edwards Lifesciences (EW) to $103 from $100 and...

23h ago

Edwards Lifesciences backs FY25 EPS view $2.56-$2.62, consensus $2.59

Backs FY25 revenue view up 9%-10%. Edwards Lifesciences (EW) will outline its strategy and share financial guidance during...

1d ago

Edwards Lifesciences sees FY26 adjusted EPS $2.80-$2.95, consensus $2.86

Sees FY26 revenue $6.4B-$6.8B, consensus $6.03B. Sees FY26 tax rate 16%-19%. “As we enter 2026, we are poised...

1d ago

Cautious Optimism for Edwards Lifesciences: Hold Rating Maintained Amid Back-End-Loaded Growth Expectations

Canaccord Genuity analyst William Plovanic has maintained their neutral stance on EW stock, giving a Hold rating today....

10h ago

Edwards Lifesciences: Strategic Initiatives and Promising Developments Drive Raised Price Target

Analyst Marie Thibault of BTIG maintained a Buy rating on Edwards Lifesciences, boosting the price target to $103.00....

23h ago

Edwards Lifesciences: A Strong Growth Opportunity in Medtech with Expanding Market Potential and Robust Product Portfolio

William Blair analyst Brandon Vazquez has maintained their bullish stance on EW stock, giving a Buy rating yesterday....

24h ago

Promising Outlook for Edwards Lifesciences: TAVR Expansion and Strong Growth Prospects Drive Buy Rating

Analyst Travis Steed from Bank of America Securities maintained a Buy rating on Edwards Lifesciences and keeping the...

1d ago

EW FAQ

What was Edwards Lifesciences’s price range in the past 12 months?

Edwards Lifesciences lowest stock price was $65.94 and its highest was $87.40 in the past 12 months.

What is Edwards Lifesciences’s market cap?

Edwards Lifesciences’s market cap is $49.16B.

When is Edwards Lifesciences’s upcoming earnings report date?

Edwards Lifesciences’s upcoming earnings report date is Feb 04, 2026 which is in 61 days.

How were Edwards Lifesciences’s earnings last quarter?

Edwards Lifesciences released its earnings results on Oct 30, 2025. The company reported $0.67 earnings per share for the quarter, beating the consensus estimate of $0.596 by $0.074.

Is Edwards Lifesciences overvalued?

According to Wall Street analysts Edwards Lifesciences’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Edwards Lifesciences pay dividends?

Edwards Lifesciences does not currently pay dividends.

What is Edwards Lifesciences’s EPS estimate?

Edwards Lifesciences’s EPS estimate is 0.62.

How many shares outstanding does Edwards Lifesciences have?

Edwards Lifesciences has 580,300,000 shares outstanding.

What happened to Edwards Lifesciences’s price movement after its last earnings report?

Edwards Lifesciences reported an EPS of $0.67 in its last earnings report, beating expectations of $0.596. Following the earnings report the stock price went down -1.234%.

Which hedge fund is a major shareholder of Edwards Lifesciences?

Currently, no hedge funds are holding shares in EW

Edwards Lifesciences Stock Smart Score

Outperform

Fundamentals

Return on Equity

13.59%

Trailing 12-Months

Asset Growth

2.32%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Edwards Lifesciences

Edwards Lifesciences (EW) is a global leader in heart valve technologies and critical care monitoring, specializing in the development and manufacturing of innovative medical devices that provide solutions for patients with advanced cardiovascular disease. The company focuses on two primary sectors: transcatheter heart valves, particularly its market-leading TAVR (transcatheter aortic valve replacement) products, and hemodynamic monitoring systems that enhance patient care in critical settings. Edwards Lifesciences is committed to improving patient outcomes through its pioneering technologies and extensive clinical research.

Edwards Lifesciences (EW) Earnings & Revenues

Historic Earnings Reports

EW Earnings Call

Q3 2025

0:00 / 0:00

Earnings Call Sentiment|Positive

Edwards Lifesciences reported strong quarterly performance with significant sales growth across multiple segments, increased full-year guidance, and positive clinical data presentations. However, there were some concerns about declining gross profit margins and upcoming changes in financial leadership.View all EW earnings summaries

EW Net sales Breakdown

75.49% Transcatheter Aortic Valve Replacement

18.04% Surgical Structural Heart

6.47% Transcatheter Mitral and Tricuspid Therapies

EW Stock 12 Month Forecast

Average Price Target

$95.10

▲(10.87% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"69":"$69","78":"$78","87":"$87","96":"$96","105":"$105"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":104,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$104.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":95.1,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$95.10</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":84,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$84.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[69,78,87,96,105],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2025","6":"Jun<br/>2025","9":"Sep<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,85.27,86.71076923076923,88.15153846153846,89.59230769230768,91.03307692307692,92.47384615384615,93.91461538461539,95.35538461538461,96.79615384615384,98.23692307692308,99.67769230769231,101.11846153846153,102.55923076923077,{"y":104,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,85.27,86.02615384615385,86.78230769230768,87.53846153846153,88.29461538461538,89.05076923076922,89.80692307692307,90.56307692307692,91.31923076923077,92.0753846153846,92.83153846153846,93.58769230769231,94.34384615384614,{"y":95.1,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,85.27,85.17230769230768,85.07461538461538,84.97692307692307,84.87923076923077,84.78153846153846,84.68384615384615,84.58615384615385,84.48846153846154,84.39076923076922,84.29307692307692,84.19538461538461,84.09769230769231,{"y":84,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":70.53,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 43, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":74.03,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":72.45,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 29, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":71.62,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":71.87,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":75.18,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":78.1,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":77.18,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":79.33,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":81.77,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":76.31,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 39,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":82.45,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":85.27,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >